EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-omics analysis reveals metabolic regulation of phosphatidylcholine, triglycerides, phosphatidylethanolamine, and cardiolipin metabolism in mouse liver with metabolic dysfunction-associated steatotic liver disease

Hong Liang, Kang Song iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0332177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Hong Liang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, Medical College, Qinghai University, Xining, Qinghai, China. Hauptthemen laut MEDLINE: Phosphatidylcholines, Phosphatidylethanolamines, Cardiolipins, Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Applied Basic Research Project of the Department of Science and Technology of Qinghai Province, Applied Basic Research Project of the Department of Science and Technology of Qinghai Provin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The dysregulation of phosphatidylcholine (PC), triglycerides (TG), phosphatidylethanolamine (PE), and cardiolipin (CL) metabolism is believed to contribute to the development of MASLD. However, little is known about the mechanisms underlying the onset of this condition. To establish a mouse model of MASLD, C57BL/6J mice were fed a high-fat diet (HFD). Lipidomics was applied to identify differences in liver lipids. RNA-sequencing and bioinformatics analyses were conducted to investigate changes in the expression of genes and pathways associated with these metabolic processes. 49 lipid classes and 3221 lipid species were identified using positive- and negative-ion pattern identification. A total of 678 differentially expressed genes were identified, of which 364 were upregulated and 314 were downregulated in the MASLD group. KEGG enrichment pathway analysis highlighted the downregulation of four genes such as Gpat4 , Gpcpd1 , Chkb , and Etnppl. These findings contribute to our understanding of the metabolic changes associated with MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhosphatidylcholinesPhosphatidylethanolaminesCardiolipinsLiverTriglyceridesFatty LiverAnimalsMiceMice, Inbred C57BLDiet, High-FatMaleLipidomicsDisease Models, AnimalLipid MetabolismMultiomics

Substanzen

PhosphatidylcholinesPhosphatidylethanolaminesCardiolipinsTriglyceridesphosphatidylethanolamine

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, Medical College, Qinghai University, Xining, Qinghai, China.
  • Endocrinology Department, Qinghai Provincial People's Hospital, Xining, Qinghai, China.

ORCID-Profile: Kang Song

Förderung

  • Applied Basic Research Project of the Department of Science and Technology of Qinghai Province
  • Applied Basic Research Project of the Department of Science and Technology of Qinghai Provin

Zitieren

APA

Liang, H., & Song, K. (2025). Multi-omics analysis reveals metabolic regulation of phosphatidylcholine, triglycerides, phosphatidylethanolamine, and cardiolipin metabolism in mouse liver with metabolic dysfunction-associated steatotic liver disease. PLOS One. https://doi.org/10.1371/journal.pone.0332177

Vancouver

Liang H, Song K. Multi-omics analysis reveals metabolic regulation of phosphatidylcholine, triglycerides, phosphatidylethanolamine, and cardiolipin metabolism in mouse liver with metabolic dysfunction-associated steatotic liver disease. PLOS One. 2025. doi:10.1371/journal.pone.0332177

BibTeX
@article{Liang2025,
  author = {Liang, Hong and Song, Kang},
  title = {Multi-omics analysis reveals metabolic regulation of phosphatidylcholine, triglycerides, phosphatidylethanolamine, and cardiolipin metabolism in mouse liver with metabolic dysfunction-associated steatotic liver disease},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0332177}
}
Kostenlos starten →